NCT00574704View on ClinicalTrials.gov

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Interventions
DRUG

CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10)

subcutaneous injections at 6 visits

DRUG

House dust mite allergen extract in combination with CYT003-QbG10-placebo

subcutaneous injections at 6 visits

DRUG

CYT003-AllQbG10 in combination with house dust mite allergen extract placebo

subcutaneous injections at 6 visits

DRUG

CYT003-QbG10-placebo in combination with house dust mite allergen extract placebo

subcutaneous injections at 6 visits

Sponsors
All Listed Sponsors
lead

Cytos Biotechnology AG

INDUSTRY